This notification concerns the acquisition by the Insud Pharma Group, through Insud Pharma S.L. and Chemo Project S.A., (“Insud Pharma Group”), of exclusive control over the Women's Healthcare Business of the Viatris Group (“Women Healthcare Business ”).